Within‐drug benefit‐risk evaluation of olanzapine long‐acting injection at one and two years of treatment

समान संसाधन

• Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study
  द्वारा: McDonnell, David P., और अन्य
  प्रकाशित: (2014)
• Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
  द्वारा: Ascher-Svanum, Haya, और अन्य
  प्रकाशित: (2014)
• A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection
  द्वारा: Atkins, Susan, और अन्य
  प्रकाशित: (2014)
• Pharmacokinetics of olanzapine long-acting injection: the clinical perspective
  द्वारा: Heres, Stephan, और अन्य
  प्रकाशित: (2014)
• Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
  द्वारा: Detke, Holland C, और अन्य
  प्रकाशित: (2010)